4.75
10.38%
-0.55
Genenta Science Spa Adr stock is traded at $4.75, with a volume of 8,421.
It is down -10.38% in the last 24 hours and up +7.95% over the past month.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
See More
Previous Close:
$5.30
Open:
$5.255
24h Volume:
8,421
Relative Volume:
0.66
Market Cap:
$93.28M
Revenue:
-
Net Income/Loss:
$-12.63M
P/E Ratio:
-9.8794
EPS:
-0.4808
Net Cash Flow:
$-12.18M
1W Performance:
-11.21%
1M Performance:
+7.95%
6M Performance:
+36.77%
1Y Performance:
-12.23%
Genenta Science Spa Adr Stock (GNTA) Company Profile
Name
Genenta Science Spa Adr
Sector
Industry
Phone
-
Address
-
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-29-23 | Resumed | ROTH MKM | Buy |
Jul-25-22 | Initiated | H.C. Wainwright | Buy |
Jan-13-22 | Initiated | Maxim Group | Buy |
Genenta Science Spa Adr Stock (GNTA) Latest News
Genenta Science CEO to present at U.S. Senate meeting - TipRanks
Genenta Science receives Buy rating amid trial approval - Investing.com
Company’s Banking Stock: Dissecting a 38.98% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider - GlobeNewswire Inc.
Genenta Science Advances Biotech EndeavorsTipRanks.com - TipRanks
Genenta Science Announces Shareholder MeetingTipRanks.com - TipRanks
DHR Stock Quote Price and Forecast - CNN
Danaher (DHR) Stock Price, News & Analysis - MarketBeat
Genenta Science Spa Adr Stock (GNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):